Matrix Stiffness Directs Early Injury and Ketogenesis Programs to Prime Kidney Repair
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000000967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Yuan Gui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut. Hauptthemen laut MEDLINE: Extracellular Matrix, Acute Kidney Injury, Kidney, Regeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, University of Pittsburgh Center for Research Computing, NIGMS NIH HHS.
Abstract (Originalsprache)
Key Points We mapped dynamic extracellular matrix remodeling in AKI and identified microfibrillar-associated protein 2 (Mfap2) as a key repair mediator. Mfap2 drove mechanometabolic signaling through a large tumor suppressor kinase 1–mediated noncanonical Hippo pathway. The Mfap2-estrogen receptor 2-3-hydroxy-3-methylglutaryl-CoA synthase 2 circuit may be a druggable node for mitigating AKI.
Background
Although traditionally considered a tubule-centric disorder, AKI is increasingly recognized as involving early and active participation of fibroblasts and pericytes, the primary producer of extracellular matrix (ECM). These cells are rapidly mobilized to injury sites to support repair. Therefore, successful recovery from AKI requires not only cellular regeneration but also a finely tuned ECM, which ensures structural support and transmits essential mechanical cues. Despite its importance, the mechanistic basis by which the ECM regulates AKI repair remains incompletely understood.
Methods
We combined genetic and pharmacologic AKI animal models with tissue engineering approaches, data-independent acquisition–based global and phosphoproteomics, and spatial transcriptomics to profile the ECM proteome landscape of decellularized kidney matrix scaffolds after injury, uncover mechanometabolic pathways driving repair, and evaluate potential therapeutic strategies.
Results
We generated a comprehensive proteomic map of the AKI kidney matrix scaffold and highlighted microfibrillar-associated protein 2 (Mfap2) as a key core matrisome component primarily derived from fibroblasts and pericytes. Mfap2 loss disrupted kidney architecture and metabolic homeostasis, aggravating AKI severity. Global proteomics revealed that Mfap2 deficiency downregulated tubular 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) through estrogen receptor 2 (Esr2)–mediated transcriptional repression and increased protein succinylation. Phosphoproteomic and spatial transcriptomic analysis showed that Mfap2 loss altered mechanotransduction, leading to mitogen-activated protein kinases hyperactivation and upregulation of large tumor suppressor kinase 1 in tubular cells, without affecting integrin receptor activity. Although large tumor suppressor kinase 1 is a key Hippo pathway kinase, its activation suppressed Esr2 transcription independently of the canonical yes-associated protein/transcriptional coactivator with PDZ-binding motif effectors and without affecting Esr2 degradation. Therapeutically, Esr2 agonist restored Hmgcs2 levels and improved kidney function in Mfap2 -deficient models.
Conclusions
Mfap2, a fibroblast/pericyte-derived core matrisome component, preserved kidney architecture and supported tubular ketogenesis by regulating Hmgcs2 via Esr2 in the AKI microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut.
- Yale Cancer Biology Institute, Yale University, West Haven, Connecticut.
- Department of Pharmacology, School of Medicine, Yale University, New Haven, Connecticut.
- Organ Pathobiology and Therapeutics Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware.
- Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
ORCID-Profile: Wenxue Li, Yanbao Yu, Silvia Liu, Yansheng Liu, Dong Zhou
Förderung
- NIDDK NIH HHS
- University of Pittsburgh Center for Research Computing
- NIGMS NIH HHS
- NCI NIH HHS
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
- Jackson Laboratory Cancer Center
Zitieren
APA
Gui, Y., Wang, Y., Li, W., Liu, J. J., Zheng, K., Li, J., Shaffer, H. W., Jones, C., Mallari, S. M., Yu, Y., Liu, S., Liu, Y., & Zhou, D. (2026). Matrix Stiffness Directs Early Injury and Ketogenesis Programs to Prime Kidney Repair. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000967
Vancouver
Gui Y, Wang Y, Li W, Liu JJ, Zheng K, Li J, et al. Matrix Stiffness Directs Early Injury and Ketogenesis Programs to Prime Kidney Repair. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000000967
BibTeX
@article{Gui2026,
author = {Gui, Yuan and Wang, Yuanyuan and Li, Wenxue and Liu, Jia-Jun and Zheng, Kelly and Li, Jianzhong and Shaffer, Henry Wells and Jones, Cameron and Mallari, Samantha Mae and Yu, Yanbao and Liu, Silvia and Liu, Yansheng and Zhou, Dong},
title = {Matrix Stiffness Directs Early Injury and Ketogenesis Programs to Prime Kidney Repair},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000000967}
}
EUVIMED